John C. Cheneval
Corporate Officer/Principal en CASTLE BIOSCIENCES, INC. .
Perfil
John C.
Cheneval is currently working as the Executive Director-Business Development at Castle Biosciences, Inc. Prior to his current position, he worked as the Vice President-Pharma Partnerships at HTG Molecular Diagnostics, Inc. from 2018 to 2021.
He also served as the Executive Vice President-Sales & Marketing at Akers Biosciences, Inc. In terms of education, Mr. Cheneval completed his undergraduate degree at LSU Medical School and Louisiana State University.
Cargos activos de John C. Cheneval
| Empresas | Cargo | Inicio |
|---|---|---|
| CASTLE BIOSCIENCES, INC. | Corporate Officer/Principal | 01/01/2021 |
Antiguos cargos conocidos de John C. Cheneval.
| Empresas | Cargo | Fin |
|---|---|---|
| HTG MOLECULAR DIAGNOSTICS, INC. | Corporate Officer/Principal | 01/01/2021 |
| MYMD PHARMACEUTICALS, INC. | Ventas & Marketing | - |
Formación de John C. Cheneval.
| Louisiana State University | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| HTG MOLECULAR DIAGNOSTICS, INC. | Commercial Services |
| CASTLE BIOSCIENCES, INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Akers Biosciences, Inc.
 Akers Biosciences, Inc. Medical SpecialtiesHealth Technology Akers Biosciences, Inc. engages in the development, manufacture, and supply of screening and testing products. Its products include clinical diagnostics and safety tests. The company was founded by Raymond Francis Akers, Jr. and Raymond F. Akers, Sr. on March 8, 1989 and is headquartered in New York, NY. | Health Technology |
- Bolsa de valores
- Insiders
- John C. Cheneval
